Aveanna Healthcare Holdings: A Look at Valuation and 2025 Guidance

Aveanna Healthcare Holdings (AVAH) raised its 2025 revenue guidance to $2.425-$2.445 billion and issued new 2026 targets. The stock price has increased by 10.01% to $9.34, building on a 15.59% year-to-date share price return. The updated guidance has put management's expectations in focus for investors, with the company expected to benefit from demographic shifts and increasing demand for home and community-based care. The valuation depends on future growth and margins, with the narrative fair value set at $10.65. However, execution risks such as Medicaid and Medicare reimbursement tightening, or caregiver hiring and retention problems, could impact the company's performance.